NCT04776005View on ClinicalTrials.gov

COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 22, 2021

Primary Completion Date

February 29, 2024

Study Completion Date

February 29, 2024

Conditions
Solid TumorHematologic MalignancyThoracic CancerCancer, Treatment-RelatedVaccine Response Impaired
Interventions
OTHER

Data collection

Assessment of the efficacy and immunogenicity of the anti-Sars-COv2 vaccines in patients treated for malignant pathology.

Trial Locations (2)

75010

RECRUITING

Saint-Louis Hospital, AP-HP, Paris

75018

RECRUITING

Bichat Hospital, AP-HP, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER